Ignite Creation Date:
2025-12-24 @ 10:46 PM
Ignite Modification Date:
2026-01-13 @ 12:40 AM
Study NCT ID:
NCT02197169
Status:
COMPLETED
Last Update Posted:
2018-07-16
First Post:
2014-07-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors
Sponsor:
DNAtrix, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-09-11
Start Date Type:
ACTUAL
Primary Completion Date:
2018-03-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-03-15
Completion Date Type:
ACTUAL
First Submit Date:
2014-07-20
First Submit QC Date:
None
Study First Post Date:
2014-07-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-12
Last Update Post Date:
2018-07-16
Last Update Post Date Type:
ACTUAL